Top Markets
Coin of the day
Wellnex Life Limited Wellnex Life Limited

Wellnex Life Limited

WNX
Rank in Stocks #34869
Wellnex Life Limited, together with its subsidiaries, develops, markets, and... Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
Share Price
$0.06559149
Last synced: 2026-08-14
Market Cap
$4.79M
Change (1 day)
1.09%
Change (1 year)
-61.95%
Country
AU
Trade Wellnex Life Limited (WNX)
Revenue for Wellnex Life Limited (WNX)
Revenue in Aug 2026 TTM: 0
According to Wellnex Life Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Wellnex Life Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$84.55B -
US
$40.13B -
US
$67.84B -
US
$4.39B -
US
$23.03B -
SG